4.8 Review

Case Report: Concurrence of Dermatomyositis and Autoimmune Blistering Diseases: Two Case Reports and a Literature Review

期刊

FRONTIERS IN IMMUNOLOGY
卷 13, 期 -, 页码 -

出版社

FRONTIERS MEDIA SA
DOI: 10.3389/fimmu.2022.855408

关键词

dermatomyositis; clinically amyopathic dermatomyositis; bullous dermatomyositis; autoimmune blistering disease; malignancy; interstitial lung disease

资金

  1. National Natural Science Foundation of China [81573037, 81872523, 82073432]
  2. National Key Clinical Specialty [2012649]
  3. Science and Technology Commission of Shanghai Municipality [134119a6100]
  4. Clinical Research Plan of SHDC [16CR3084B]
  5. Shanghai Yiyuan Rising Star Outstanding Young Medical Talents
  6. Shanghai Municipal Education Commission-Gaofeng Clinical Medicine Grant Support [20172009]

向作者/读者索取更多资源

This article reports two cases of clinically amyopathic dermatomyositis (CADM) with autoimmune blisters. The article discusses the differences between the two diseases in terms of clinical presentation, pathogenesis, therapy, and the risk of complications.
Dermatomyositis (DM) is an idiopathic inflammatory myopathy primarily involving skin and muscles. Clinically amyopathic dermatomyositis (CADM), a subset of DM, presents with characteristic cutaneous manifestations without clinical evidence of myositis. Although rare, vesiculobullous eruptions could develop in DM patients. Such bullous DM is commonly considered a sign of internal malignancy. However, some cases with similar presentations were diagnosed as autoimmune blistering disease eventually. Herein, we reported two cases of CADM with autoimmune blisters formed. Case 1 presented with vesicles and was diagnosed with CADM initially. However, this patient developed blisters again years later and was diagnosed with pemphigus foliaceous (PF) accordingly. Case 2, with a history of nasopharyngeal carcinoma and CADM, developed bullous pemphigoid several days after using a heat patch on her abdomen. The association between disease occurrence and local skin damage might provide more evidence to support the epitope spreading hypothesis. Moreover, we reviewed related literature and discussed the differences between the two disease entities in clinical presentations, pathogenesis, therapy, and the risk of complications.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据